Melissa in the Morning: Flu Vaccines

The FDA is agreeing to review Moderna's influenza vaccine. Officials defended the initial decision, saying the company should have given a higher-strength vaccine to older patients in the control arm of its trial. However, Moderna made revisions to its approach and is now seeking full approval for the shot for adults between 50 and 64 years old as well as accelerated approval for those aged 65 and above. We talked about this with Dr. Browne of Griffin Health.

Image Courtesy of Griffin Health and Dr. Fred Browne